Results 1,501-1,520 of 3,998 for speaker:Michael Harty

Joint Oireachtas Committee on Health: Lyme Disease: Discussion (28 Nov 2018)

Michael Harty: Does any other member of the panel wish to make a comment?

Joint Oireachtas Committee on Health: Lyme Disease: Discussion (28 Nov 2018)

Michael Harty: Unfortunately I have to vacate the Chair for a period. Deputy O'Reilly will assume the Chair. The fist contributor will be Deputy Donnelly. If Deputy O'Reilly wishes to contribute, Deputy Durkan will assume the Chair.

Written Answers — Department of Health: Departmental Correspondence (28 Nov 2018)

Michael Harty: 189. To ask the Minister for Health his plans to appoint an independent expert to examine claims contained in new documentation given to him regarding missing blood samples that were taken for an investigation (details supplied); if the independent expert will also advise if a public inquiry is warranted; and if he will make a statement on the matter. [49617/18]

Written Answers — Department of Public Expenditure and Reform: Flood Relief Schemes (27 Nov 2018)

Michael Harty: 208. To ask the Minister for Public Expenditure and Reform the status of the long promised Clonlara flood relief scheme following the decision of Clare County Council to withdraw its plans as a result of submissions from the National Parks and Wildlife Service and an environmentalist; the implications the delay has for the commencement and completion of this urgent scheme; and if he will make...

Brexit: Motion (21 Nov 2018)

Michael Harty: I thank the Tánaiste and the Minister of State, Deputy McEntee, for being here this evening. Brexit is bad for everybody, no matter what format it takes. The UK has sought it but the consequent adjustments that all will have to make to accommodate Brexit are mostly negative. Brexit will have profoundly negative economic implications for Ireland regardless of it being a hard or soft...

Older People: Motion [Private Members] (21 Nov 2018)

Michael Harty: It goes without saying that keeping people in their homes and communities provides the best value for money. It also gives them a superior quality of life. Regardless of what nursing homes do, with the best intentions in the world, it is very hard to prevent people from becoming institutionalised in them. They have a significant amount of activities and other supports that allow residents...

Joint Oireachtas Committee on Health: Business of Joint Committee (21 Nov 2018)

Michael Harty: As we have a quorum, I call the meeting to order. Deputy Kelly has turned up, so we will now proceed to consider housekeeping matters in private session. Is that agreed? Agreed.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: The purpose of this morning's meeting is to consider the implementation of the recommendations in the committee's report on evaluating orphan drugs, which was published last February. We will hold two sessions on the topic. The first session will involve Rare Diseases Ireland, which is the umbrella body for patients with rare diseases and will present to the committee first. The second...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: We will open the discussion to members. I call Deputy Donnelly.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: I thank Deputy Kelly. Deputy O'Reilly is next.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: I invite Mr. Mitchell to respond.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: The committee's report made a recommendation that there would be a review of the 2013 Act to see whether there was any legislative barrier to the process. Have the witnesses been able to identify any legislative barrier in the Act that inhibits the provision of orphan drugs?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: At a previous hearing, a recommendation or suggestion was made that orphan drugs need to be dealt with differently to standard drugs but the legislation does not allow for a distinction between a standard or common drug and an orphan drug. A recommendation was made that the legislation would be reviewed to see whether amendments to the legislation were necessary to allow a different process...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: I will allow the Deputy back in to expand on that in a few minutes. I thank the witnesses for those responses.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: I am conscious of the fact that we have the HSE and the NCPE outside. Was there a specific question in that?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: On behalf of the committee, I thank Mr. Watt, Ms McGrath and Mr. Mitchell for coming to give their evidence. Of course, they can wait and observe the next session.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: The committee will now continue its consideration of the implementation of the recommendations contained in the report on the evaluation of orphan drugs which was published last February. On its behalf, from the HSE I welcome Professor Michael Barry, clinical director of the National Centre for Pharmacoeconomics; Mr. John Hennessy, national director of acute strategy and planning; and Mr....

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: Was this submitted?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: When was that?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Michael Harty: Was it submitted this morning?